Strong year-on-year uplift in revenue – H1 FY18 revenues were $798,923, an increase of 502% on the same period last year, as the Company aggressively pursued monetisation of its Systems and Services businesses
How good is that!!
- Forums
- ASX - By Stock
- SYT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-2
Featured News
Add SYT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online